Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses

Triple inhaled corticosteroid (ICS)/long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA) therapy is recommended for symptomatic patients with chronic obstructive pulmonary disease (COPD) and at risk of exacerbations. However, the benefits versus side-effects of triple inhaled the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ERJ Open Res
Autori principali: Halpin, David M.G., Birk, Ruby, Brealey, Noushin, Criner, Gerard J., Dransfield, Mark T., Hilton, Emma, Lomas, David A., Zhu, Chang-Qing, Lipson, David A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: European Respiratory Society 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5934530/
https://ncbi.nlm.nih.gov/pubmed/29750142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00119-2017
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi